SARS-CoV-2 antibody responses in patients with acute leukaemia.

O'Nions, J; Muir, L; Zheng, J; Rees-Spear, C; Rosa, A; Roustan, C; Earl, C; Cherepanov, P; Gupta, R; Khwaja, A; Jolly, C; McCoy, L E

O'Nions, J; Muir, L; Zheng, J; Rees-Spear, C; Rosa, A; Roustan, C; Earl, C; Cherepanov, P; Gupta, R; Khwaja, A; Jolly, C; McCoy, L E.

Afiliação

O'Nions J; Department of Haematology, University College London NHS Foundation Trust, London, UK. jenny.onions@nhs.net.
Muir L; Division of Infection and Immunity, University College London, London, UK.
Zheng J; Department of Haematology, University College London NHS Foundation Trust, London, UK.
Rees-Spear C; Division of Infection and Immunity, University College London, London, UK.
Rosa A; The Francis Crick Institute, London, UK.
Roustan C; The Francis Crick Institute, London, UK.
Earl C; The Francis Crick Institute, London, UK.
Cherepanov P; The Francis Crick Institute, London, UK.
Gupta R; Department of Haematology, University College London NHS Foundation Trust, London, UK.
Khwaja A; UCL Cancer Institute London, Paul O'Gorman Building, London, UK.
Jolly C; Department of Haematology, University College London NHS Foundation Trust, London, UK.
McCoy LE; UCL Cancer Institute London, Paul O'Gorman Building, London, UK.

Leukemia ; 35(1): 289-292, 2021 01.

Article em En | MEDLINE | ID: mdl-33299142

Assuntos

COVID-19; Leucemia Linfocítica Crônica de Células B; Formação de Anticorpos; Humanos; Imunoglobulina G; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google